EndocrineIn Stock
Ipamorelin
Selective Growth Hormone Secretagogue
10mg · Lyophilised Powder
$75.00
Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist. Research highlights its high specificity for GH release without significant co-stimulation of cortisol, prolactin, or ACTH — making it a valuable tool in neuroendocrine studies.
Form
Lyophilised Powder
Purity
≥99% (HPLC)
Storage
2–8°C / 36–46°F
Use
Research Only
1
Secure checkout via PayID · Free shipping over $150
Research Overview
Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH₂) is a third-generation growth hormone releasing peptide (GHRP) and selective ghrelin receptor (GHS-R1a) agonist. Unlike first and second generation GHRPs, ipamorelin demonstrates remarkable selectivity for GH release with minimal effect on cortisol, prolactin, acetylcholine, or ACTH secretion.
Seminal research by Raun et al. (1998) demonstrated that ipamorelin is the first GHRP to combine the high potency of GHRP-6 with the high selectivity of GHRP-2, establishing it as a valuable research tool for studying the GH/IGF-1 axis without the confounding effects of cortisol elevation.
Studies in rat models have demonstrated dose-dependent GH release with a rapid onset and return to baseline, suggesting a favorable pharmacokinetic profile for research protocols requiring precise temporal control of GH secretory events.
Research has also examined ipamorelin in the context of bone density studies, body composition models, and sleep architecture studies given GH's well-documented role in slow-wave sleep regulation.
Research Use Only
For in vitro research and laboratory use only. Not approved by the TGA, FDA, or any regulatory authority for human or veterinary use. By purchasing, you confirm you are a qualified researcher using this compound solely for lawful scientific research.
